Ivermectin, a widely used antiparasitic drug, has garnered significant attention in recent years due to its versatile applications in both veterinary and human medicine. Ivermectin Stromectol Tablet represents a key formulation in human use. Understanding the mechanism of action of ivermectin is crucial for healthcare professionals and researchers alike. In this comprehensive article, we'll delve into the intricate workings of this remarkable drug, exploring how it affects parasites, its impact on human cells, and why it's ineffective against certain pathogens.
We provide Ivermectin Tablet, please refer to the following website for detailed specifications and product information.
Product: www.bloomtechz.com/oem-odm/tablet/ivermectin-stromectol-tablet.html
| 1.General Specification(in stock) (1)Injection N/A (2)Tablet 360mg/Tablet,Package:100 tablets/Bottle;80 bottles/Box (3)API(Pure powder) PE/Al foil bag/ paper box for Pure powder HPLC≥99.0% (4)Pill press machine https://www.achievechem.com/pill-press 2.Customization: We will negotiate individually, OEM/ODM, No brand, for secience researching only. Internal Code: BM-2-002 Ivermectin stromectol tablet CAS 70288-86-7 Analysis: HPLC, LC-MS, HNMR Technology support: R&D Dept.-4 |
|
How does ivermectin paralyze parasites in the human body?
Ivermectin's primary mechanism of action revolves around its ability to interfere with the nervous system of parasites. This potent antiparasitic agent targets specific channels in the nerve and muscle cells of invertebrates, leading to paralysis and eventual death of the parasites.
● Glutamate-gated chloride channels: The key target
The cornerstone of ivermectin's efficacy lies in its interaction with glutamate-gated chloride channels (GluCls). These channels are unique to invertebrates and are not present in mammals, making ivermectin particularly selective in its action. When ivermectin stromectol tablet binds to these channels, it causes them to open and stay open, allowing an influx of chloride ions into the nerve and muscle cells.
● Hyperpolarization and paralysis
The increased chloride ion concentration within the cells leads to hyperpolarization, a state where the cell's electrical charge becomes more negative. This hyperpolarized state inhibits normal nerve function and muscle contraction, effectively paralyzing the parasite. As a result, the immobilized parasites are unable to feed, reproduce, or maintain their position within the host, ultimately leading to their demise.
● Additional mechanisms of action
While the primary mechanism involves GluCls, ivermectin also affects other ligand-gated ion channels, such as GABA receptors. This multi-faceted approach enhances its antiparasitic effects and contributes to its broad spectrum of activity against various parasitic species.
Does ivermectin affect human nerve cells like it does in parasites?
A common concern when using antiparasitic drugs is their potential impact on human cells. In the case of ivermectin, its selectivity for invertebrate channels provides a significant safety margin for use in humans.
|
|
Minimal impact on human nerve cellsUnlike parasites, human nerve cells do not possess glutamate-gated chloride channels, which are the primary targets of ivermectin. This fundamental difference in cellular structure explains why ivermectin can effectively paralyze parasites without causing similar effects in humans. |
Blood-brain barrier protectionAnother layer of protection for human nerve cells is the blood-brain barrier (BBB). The BBB is a highly selective semipermeable border that separates the circulating blood from the brain and extracellular fluid in the central nervous system. Ivermectin, particularly when administered as Stromectol tablets, has limited ability to cross the BBB in humans. This restriction further minimizes any potential effects on human nerve cells. |
|
|
|
P-glycoprotein and ivermectin effluxP-glycoprotein, a transmembrane protein that acts as an efflux pump, plays a crucial role in preventing ivermectin from accumulating in human cells. This protein actively pumps ivermectin out of cells, maintaining low intracellular concentrations and further reducing the risk of adverse effects on human nerve cells. |
Why is ivermectin ineffective against bacteria and viruses?
While ivermectin has shown remarkable efficacy against various parasites, it is not effective in treating bacterial or viral infections. Understanding the reasons behind this limitation is essential for appreciating the drug's specificity and appropriate use.
► Lack of target structures in bacteria
Bacteria, being prokaryotic organisms, have a fundamentally different cellular structure compared to parasites. They lack the complex nervous systems and specialized ion channels that ivermectin targets in parasites. As a result, the drug's primary mechanism of action is ineffective against bacterial pathogens.
► Absence of relevant pathways in viruses
Viruses, as non-cellular entities, do not possess the cellular machinery or ion channels that ivermectin affects. Their replication and survival mechanisms are entirely different from those of parasites or bacteria. Consequently, ivermectin's mode of action does not interfere with viral processes, rendering it ineffective as an antiviral agent.
► Specificity of antiparasitic action
The specificity of Stromectol tablets' mechanism of action is both a strength and a limitation. While it allows for targeted treatment of parasitic infections with minimal side effects, it also means that the drug is not a broad-spectrum antimicrobial agent. This specificity underscores the importance of accurate diagnosis and appropriate drug selection in treating infectious diseases.
► Potential indirect effects on viral infections
Although ivermectin does not directly act on viruses, some studies have suggested potential indirect effects on viral infections through modulation of host immune responses. However, these effects are not well-established and require further research to determine their clinical relevance.
► Importance of targeted therapy
The ineffectiveness of ivermectin against bacteria and viruses highlights the importance of targeted therapy in medicine. Different classes of pathogens require specific treatment approaches, and using the right tool for the job is crucial for successful patient outcomes.
Conclusion
The mechanism of action of Ivermectin Stromectol Tablet is a testament to the complexity and specificity of modern pharmacology. By targeting unique structures in parasitic organisms, ivermectin achieves its remarkable antiparasitic effects while minimizing impact on human cells. Understanding these mechanisms not only enhances our appreciation of this drug but also paves the way for the development of new, targeted therapies for various diseases.
As we continue to unravel the intricacies of drug mechanisms, it's crucial to rely on accurate information and expert guidance in the use of medications like ivermectin. For those in the pharmaceutical, chemical, and related industries seeking high-quality chemical products, Shaanxi BLOOM TECH Co., Ltd. stands as a reliable partner. With our state-of-the-art GMP-certified production facilities and expertise in advanced chemical reactions and purification techniques, we are committed to delivering top-tier products to meet your specific needs.
Whether you're in the pharmaceutical industry looking for bulk chemical purchases, or in the polymer, paints, water treatment, oil and gas, or specialty chemicals sectors, BLOOM TECH has the capabilities to support your requirements. To learn more about our chemical products and how we can assist your business, please don't hesitate to reach out to us at Sales@bloomtechz.com. Our team of experts is ready to provide you with the solutions you need to drive innovation and success in your industry.
References
1. Campbell, W. C. (2012). History of avermectin and ivermectin, with notes on the history of other macrocyclic lactone antiparasitic agents. Current Pharmaceutical Biotechnology, 13(6), 853-865.
2. Laing, R., Gillan, V., & Devaney, E. (2017). Ivermectin – Old Drug, New Tricks? Trends in Parasitology, 33(6), 463-472.
3. Crump, A., & Ōmura, S. (2011). Ivermectin, 'wonder drug' from Japan: the human use perspective. Proceedings of the Japan Academy, Series B, 87(2), 13-28.
4. Caly, L., Druce, J. D., Catton, M. G., Jans, D. A., & Wagstaff, K. M. (2020). The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Research, 178, 104787.